 allogen marrow transplant patient acut myeloid leukemia first remiss random trial irradi random trial Gy versu Gy total bodi irradi tbi patient acut myeloid leukemia allogen marrow transplant first complet remiss patient mg/kg cyclophosphamid tbi hla-ident sibl cyclosporin methotrex prophylaxi acut graft-versus-host diseas gvhd thirty-four patient fraction irradi daili day fraction day actuari probabl relapse-fre surviv patient Gy Gy probabl relaps Gy group Gy group probabl transplant-rel mortal probabl moder acut gvhd Gy group Gy group patient irradi immunoprophylaxi incid acut gvhd dose tbi probabl relaps surviv increas mortal relaps